Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15)
about
Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD)Structure of the FP domain of Fbxo7 reveals a novel mode of protein-protein interactionFBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophyFBXO7 Y52C polymorphism as a potential protective factor in Parkinson's diseaseDevelopmental exposure to organophosphates triggers transcriptional changes in genes associated with Parkinson's disease in vitro and in vivoFamilial atypical parkinsonism with rare variant in VPS35 and FBXO7 genes: A case report.Dopaminergic neuronal loss and dopamine-dependent locomotor defects in Fbxo7-deficient zebrafish.The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE).Splicing: is there an alternative contribution to Parkinson's disease?CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia.Ubiquitin and Parkinson's disease through the looking glass of genetics.Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in miceMechanistic contributions of FBXO7 to Parkinson disease.Mitochondrial Regulation by PINK1-Parkin Signaling
P2860
Q26752685-1EFE0A13-8EF5-423E-9E81-1F68495BBCFDQ27688887-D3403B19-297B-4CE1-9FE6-4F479269D226Q28117902-240CF7B2-4946-4A52-BF29-81C6F131D618Q28118464-F4236F75-7E23-4FBF-AFEB-FC9C312C310FQ28393707-D000B345-0726-42C8-8E0E-6A5C83E51B81Q30829553-2F794B57-3797-46A6-9C66-4032D097929EQ34469890-AFCD23B3-D40F-4FBE-BAFC-CBE011BE8CB9Q35191687-D7DFC950-D4DF-49B2-ADB6-086EDC877466Q36069844-A00C5EFC-90DF-4108-85A8-D00C55A4D606Q36809438-2C2C1F1C-A825-4767-B08D-034DA9E4C41EQ39241365-C241A416-099A-486D-9F8E-CE5E715BF08FQ41730755-868E052D-7473-440D-AFCD-FFE474EE7486Q47406006-AA8B193E-4283-4B02-B6E9-DDA63BF24D15Q58905388-FE3F6C80-86CF-49AE-8B6D-1F8BBDA3004C
P2860
Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15)
description
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique PLoS ONE
@fr
artículu científicu espublizáu en 2011
@ast
im Februar 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2011/02/11)
@sk
vědecký článek publikovaný v roce 2011
@cs
wetenschappelijk artikel (gepubliceerd op 2011/02/11)
@nl
наукова стаття, опублікована в лютому 2011
@uk
name
Loss of nuclear activity of th ...... an-pyramidal syndrome (PARK15)
@ast
Loss of nuclear activity of th ...... an-pyramidal syndrome (PARK15)
@en
Loss of nuclear activity of th ...... an-pyramidal syndrome (PARK15)
@nl
type
label
Loss of nuclear activity of th ...... an-pyramidal syndrome (PARK15)
@ast
Loss of nuclear activity of th ...... an-pyramidal syndrome (PARK15)
@en
Loss of nuclear activity of th ...... an-pyramidal syndrome (PARK15)
@nl
prefLabel
Loss of nuclear activity of th ...... an-pyramidal syndrome (PARK15)
@ast
Loss of nuclear activity of th ...... an-pyramidal syndrome (PARK15)
@en
Loss of nuclear activity of th ...... an-pyramidal syndrome (PARK15)
@nl
P2093
P2860
P3181
P1433
P1476
Loss of nuclear activity of th ...... an-pyramidal syndrome (PARK15)
@en
P2093
Agnese Loda
Ben A. Oostra
Cokkie H. Wouters
Esther De Graaff
Frans W. Verheijen
Guido J. Breedveld
Lies-Anne Severijnen
Marieke C. J. Dekker
Rob Willemsen
Tianna Zhao
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0016983
P407
P577
2011-02-11T00:00:00Z